The 7investing Podcast cover image

The 7investing Podcast

Latest episodes

undefined
Aug 11, 2021 • 53min

A Look at the Real Impact of “Inflation”

There has been good news and bad news for American consumers. Wages, especially at the bottom end of the workforce have been rising, but those gains have seen their impact muted by price increases in a number of areas. Some have called this inflation, but it’s not that simple. While there likely is some inflation in the market, there are also clear supply chain issues that have driven up prices for cars, appliances, some electronics, and more. Maxx Chatsko joins Dan Kline on “7investing Now” live at noon eastern to discuss what this might mean for the stock market. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Aug 10, 2021 • 16min

7investing Market Focus: Fastly’s “Horror Novel” Earnings Report $FSLY (8/5/21)

Fastly’s growth rates have come to a screeching halt, and its customers are infuriated over a recent network outage. Are these short-term blips that are correctable? Or are they indicative of longer-term problems with the company’s technology? 7investing lead advisors Anirban Mahanti and Dan Kline discuss Fastly’s Content Delivery Network and whether it is sustainable as a long-term investment. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Aug 10, 2021 • 16min

7investing Market Focus: Robinhood’s Volatility and Targeting Education $HOOD $TGT (8/4/21)

After a disappointing first day of trading, Robinhood’s stock has regained confidence from investors. Is this just short-term noise, or are there important new developments that long-term investors should be aware of? 7investing lead advisors Dana Abramovitz and Steve Symington take a closer look at one of the stock market’s most recent IPOs. The two also dig into a new educational program that Target is offering to its employees. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Aug 10, 2021 • 16min

7investing Market Focus: Simon’s Malls Are Returning Back to Normal $SPG (8/3/21)

Simon Property Group has disclosed its sales have now fully recovered to their 2019 levels. Post-pandemic, what items are consumers most interested in buying from malls? 7investing lead advisors Dan Kline and Maxx Chatsko discuss why certain “A-List” malls could be lucrative long-term investment opportunities that are benefiting from pent-up demand. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Aug 9, 2021 • 19min

7investing Market Focus: Square’s $29 Billion Acquisition Looks Like a Good Fit $SQ (8/2/21)

Square’s acquisition of Afterpay will give it access to the fast-growing Buy Now Pay Later market. Was this a good acquisition, or was the price tag too expensive? 7investing lead advisors Anirban Mahanti and Steve Symington discuss Square’s underappreciated network effects and why the company is so excited about integrating BNPL into its existing Cash App. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Aug 5, 2021 • 32min

The Future of Media with Daniel Anstandig, CEO of Futuri

Daniel Anstandig, the CEO and Co-Founder of Futuri -- an innovative company focusing on enhancing the effectiveness of media through an enterprise tech platform --  joined the 7investing podcast to explain what his company does and share his thoughts on the future of media. Futuri has targeted making content companies more effective. The emerging brand uses an artificial intelligence (AI) system to “detect stories bubbling to the surface that are going to go viral, allowing producers (podcasts, TV, online, radio) an opportunity to get ahead of the story and catch the news as it breaks. It also helps media target specific audiences, stories, demographics and more to make them more profitable.” That’s a goal that could help companies produce content that makes more money. It’s also a concept that some editorial professionals will bristle at. Anstandig explained how his product can work to benefit companies striving to create high-quality content. He also addressed some of the pitfalls that can happen when people overuse AI rather than using it as a tool to help them make better decisions. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Aug 3, 2021 • 46min

The 3 Frameworks for Evaluating Gene Editing Stocks

When Caribou Biosciences (NASDAQ: CRBU) became the seventh publicly-traded CRISPR stock in July 2021, I saw an exchange on social media. One person asked why the company sported a market valuation of $900 million when another newly-public CRISPR stock, Verve Therapeutics (NASDAQ: VERV), was valued near $2.3 billion. "Is there any reason for this other than the timing of the IPOs?", asked the individual. The thread received multiple responses confirming the seemingly large valuation difference between the two companies, with others "agreeing" or responding that they were buying Caribou Biosciences because of it. That was 100% the wrong take. I've observed similar arguments among individual investors within the gene editing space. However, it's important to acknowledge that there are significant differences between gene editing approaches and technology platforms. Caribou Biosciences and Verve Therapeutics might both be using CRISPR systems, but that's where the overlap ends. They're developing completely different tools that have almost nothing in common. Individual investors don't necessarily need to have a deep technical understanding of gene editing tools, but I would argue that there's a minimum level of information required to responsibly invest in the field. Unfortunately, the way the internet works means most investors aren't provided with the information they need. Let's fix that. In this episode of the podcast, 7investing Lead Advisors Maxx Chatsko (me) and Dan Kline introduce simple frameworks for evaluating opportunities and challenges in gene editing. These can be summarized as follows: The Emerging Approaches: There's first-generation tools (gene editing), second-generation tools (base editing), and third-generation tools (prime editing). These approaches are not limited to any specific system. For example, there are CRISPR, TALEN, ARCUS, and other tools capable of performing base editing. The Major Applications: There are knock outs, insertions, activations, precise corrections, knock ins, and other uses of gene editing tools. Each has advantages and disadvantages. The Major Administration Routes: This primarily comes down to in vivo (inside the body) and ex vivo (outside the body). Each has advantages and disadvantages. In addition to this podcast introducing the three frameworks, 7investing Lead Advisor Maxx Chatsko has written an in-depth article explaining these frameworks and how each gene editing stock fits into each -- and it's free to read! Publicly-traded companies mentioned in this podcast include Alnylam Pharmaceuticals, Beam Therapeutics, Caribou Biosciences, Cellectis, CRISPR Therapeutics, Editas Medicine, Graphite Bio, Intellia Therapeutics, Precision BioSciences, Sana Biotechnology, and Verve Therapeutics. 7investing Lead Advisors may have positions in the companies that are mentioned. This interview was originally recorded on August 2nd, 2021 and was first published on August 3rd, 2021.
undefined
Aug 2, 2021 • 15min

7investing Market Focus: Robinhood’s IPO: What's Under the $HOOD? (7/29/21)

Robinhood’s first day as a publicly-traded company didn’t quite go as planned. Is this company a long-term investment opportunity? 7investing lead advisors Dana Abramovitz and Simon Erickson analyze how Robinhood makes its money and whether those revenue streams are long-term sustainable. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Aug 2, 2021 • 15min

7investing Market Focus: The Fed’s Big Meeting (7/28/21)

Markets have been propped up by low interest rates for quite some time, yet inflation looms on everyone’s mind. What could be the impact for long-term investors? 7investing lead advisors Maxx Chatsko and Steve Symington share their take on the Fed’s recent actions, the potential for transitory inflation, and certain pockets of the economy that are a bit ‘frothier’ than others. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Aug 2, 2021 • 16min

7investing Market Focus: COVID’s Impact on Global Supply Chains (7/27/21)

The world is adjusting to the new normal of the COVID pandemic. But what could resurging cases of its Delta variant mean for the stock market? 7investing lead advisors Anirban Mahanti and Dan Kline evaluate the impact of the pandemic on companies with international supply chains and share their advice for long-term investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode